25-Hydroxyvitamin D: functional outcomes in infants and young children.
Vitamin D deficiency occurs in the United States in exclusively breastfed infants who have high levels of skin pigmentation, inadequate vitamin D supplementation, and insufficient sunlight exposure. I review serum 25-hydroxyvitamin D [25(OH)D] concentrations and functional outcomes of vitamin deficiency in young children and breastfed and nonbreastfed infants. These outcomes include the presence or absence of vitamin D deficiency rickets, bone mineral content, and serum parathyroid hormone concentration. Daily vitamin D supplements of 400 IU/L keep serum 25(OH)D concentrations higher than 50 nmol/L and prevent rickets in infants and young children. The available evidence is not sufficient to support the use of bone mineral content or parathyroid hormone concentrations in infants and young children as functional outcomes to define deficient or sufficient levels of 25(OH)D. I therefore propose a research agenda to establish the functional definitions of vitamin D sufficiency or deficiency in infants and young children.
Greer
Frank R
FR
Department of Pediatrics, University of Wisconsin, Madison, WI, USA. frgreer@pediatrics.wisc.edu
D015415:Biomarkers / Q000097:blood; D015519:Bone Density / Q000187:drug effects / Q000502:physiology; D050071:Bone Density Conservation Agents / Q000008:administration & dosage / Q000378:metabolism / Q000502:physiology*; D001942:Breast Feeding / Q000009:adverse effects; D002675:Child, Preschool; D019587:Dietary Supplements; D005260:Female; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D009751:Nutritional Requirements; D010281:Parathyroid Hormone / Q000097:blood; D012279:Rickets / Q000453:epidemiology / Q000209:etiology / Q000517:prevention & control; D012880:Skin Pigmentation; D013472:Sunlight / Q000009:adverse effects; D014807:Vitamin D / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000097:blood / Q000378:metabolism / Q000502:physiology*; D014808:Vitamin D Deficiency / Q000453:epidemiology* / Q000209:etiology / Q000517:prevention & control
D015415:Biomarkers; D050071:Bone Density Conservation Agents; D010281:Parathyroid Hormone; D014807:Vitamin D; C104450:25-hydroxyvitamin D